SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 深圳市海普瑞藥業集團股份有限公司

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

HKD '000

Supervisors

1 Su, Jilan 蘇紀蘭 Supervisor 278 97 39 414
2 Tang, Haijun (1978) 唐海均 Supervisor 336 112 45 493
3 Zheng, Zehui 鄭澤輝 Sup Ch 100 100
Total 0 714 209 84 0 1,007

Directors

4 Chen, Junfa (1964) 陳俊發 INED 100 100
5 Li, Li (Shenzhen Hepalink) 李鋰 Ch, Co-Fdr 1,472 1,437 54 2,963
6 Li, Tan 李坦 ED, Co-Fdr 1,188 1,221 9 2,418
7 Lu, Chuan 呂川 INED 100 100
8 Shan, Yu 單宇 ED, GM, Co-Fdr 1,301 1,330 8 2,639
9 Wang, Zhaohui (1977) 王肇輝 INED 100 100
10 Zhang, Bin (1977) 張斌 ED 562 11 573
Total 300 4,523 3,988 82 0 8,893
Grand total 300 5,237 4,197 166 0 9,900

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 300 6,563 5,960 106 0 12,929 Report
Total 300 6,563 5,960 106 0 12,929

HKD'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 300 4,014 3,989 73 0 8,376 Report
2022-12-31 300 4,523 3,988 82 0 8,893 Report
2021-12-31 300 12,001 0 104 0 12,405 Report
2020-12-31 300 12,203 13,200 50 0 25,753 Report
Total 1,200 32,741 21,177 309 0 55,427

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top